South Africa’s health minister says the country will begin administering the unapproved Johnson & Johnson vaccine to its front-line health workers next week.
The workers will be monitored to see what protection the J&J shot provides from COVID-19, and particularly against the coronavirus variant dominant in the country.
Health Minister Zweli Mkhize says that South Africa scrapped its plans to use the Oxford-AstraZeneca vaccine because it “does not prevent mild to moderate disease” of the variant dominant in South Africa.
Mkhize asserts that the J&J vaccine, which is still being tested internationally, is safe.
He says those shots will be followed by a campaign to vaccinate an estimated 40 million people in South Africa by the end of the year. The minister said the country will be using the Pfizer vaccine and others, possibly including the Russian Sputnik V, Chinese Sinopharm and Moderna vaccines.
Illustrative — Thabisle Khlatshwayo, receives her second shot at a vaccine trial facility for AstraZeneca at Soweto’s Chris Sani Baragwanath Hospital outside Johannesburg, South Africa, Nov. 30, 2020 (AP Photo/Jerome Delay)
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you, David Horovitz, Founding Editor of The Times of Israel
From 
Add ToI as a Preferred Source on Google
